Overview

Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed Conditions

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to prove the bioequivalence of Roxane Laboratories' Tinidazole 500 mg Tablet under fed conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Roxane Laboratories
Treatments:
Tinidazole